Ogawa Kazuma, Takeda Takuya, Yokokawa Masaru, Yu Jing, Makino Akira, Kiyono Yasushi, Shiba Kazuhiro, Kinuya Seigo, Odani Akira
Institute for Frontier Science Initiative, Kanazawa University.
Graduate School of Medical Sciences, Kanazawa University.
Chem Pharm Bull (Tokyo). 2018;66(6):651-659. doi: 10.1248/cpb.c18-00081.
Radiolabeled cyclic peptides containing the (Arg-Gly-Asp) RGD sequence for use in positron emission tomography (PET) imaging, single-photon emission computed tomography (SPECT) imaging, and targeted radionuclide therapy of cancer have been reported. In this study, RGD was used as a model carrier peptide for diagnosis and therapy of cancer. To evaluate the characteristics of radiohalogen-labeled peptides, several kinds of labeled RGD peptides [I-c(RGDyK), Br-c(RGDyK), [I]SIB-c(RGDfK), [Br]SBrB-c(RGDfK), [I]SIB-EG-c(RGDfK), and [Br]SBrB-EG-c(RGDfK)] were designed, prepared, and evaluated. In these initial studies, Br (t=57.0 h) and I (t=59.4 d) were used because of their longer half-lives. Precursor peptides were synthesized using a standard 9-fluorenylmethyloxycarbonyl (Fmoc)-based solid-phase methodology. Radiolabeled peptides were prepared by chloramine-T method or conjugation of RGD peptides with [I]N-succinimidyl 3-iodobenzoate ([I]SIB) or [Br]N-succinimidyl 3-bromobenzoate ([Br]SBrB). Measurement of the partition coefficients, integrin binding assay, and biodistribution experiments in tumor-bearing mice were performed. I and Br labeling were successfully performed using similar methods, and in vitro characteristics and biodistributions were similar between the I-labeled and corresponding Br-labeled peptides. [I]SIB- and [Br]SBrB-conjugated RGD peptides showed higher partition coefficients, lower tumor uptakes, and higher intestinal uptake than I-c(RGDyK) and Br-c(RGDyK). [I]SIB-EG-c(RGDfK) and [Br]SBrB-EG-c(RGDfK), which possess an ethylene glycol linker, decreased lipophilicity and uptake in intestine compared with [I]SIB-c(RGDfK) and [Br]SBrB-c(RGDfK), which possess no linker. However, the improvement in biodistribution of [I]SIB-EG-c(RGDfK) and [Br]SBrB-EG-c(RGDfK)] was insufficient. In conclusion, directly radiohalogenated c(RGDyK) peptides are potentially more useful for tumor imaging and therapy than indirectly radiohalogenated ones.
含有(精氨酸 - 甘氨酸 - 天冬氨酸)RGD序列的放射性标记环肽已被报道用于正电子发射断层扫描(PET)成像、单光子发射计算机断层扫描(SPECT)成像以及癌症的靶向放射性核素治疗。在本研究中,RGD被用作癌症诊断和治疗的模型载体肽。为了评估放射性卤素标记肽的特性,设计、制备并评估了几种标记的RGD肽[I - c(RGDyK)、Br - c(RGDyK)、[I]SIB - c(RGDfK)、[Br]SBrB - c(RGDfK)、[I]SIB - EG - c(RGDfK)和[Br]SBrB - EG - c(RGDfK)]。在这些初步研究中,由于溴(t = 57.0 h)和碘(t = 59.4 d)的半衰期较长,所以使用了它们。前体肽采用基于标准9 - 芴甲氧羰基(Fmoc)的固相方法合成。放射性标记肽通过氯胺 - T法或RGD肽与[I]N - 琥珀酰亚胺基3 - 碘苯甲酸酯([I]SIB)或[Br]N - 琥珀酰亚胺基3 - 溴苯甲酸酯([Br]SBrB)的偶联来制备。进行了分配系数的测量、整合素结合测定以及在荷瘤小鼠中的生物分布实验。使用相似的方法成功实现了碘和溴的标记,并且碘标记和相应溴标记的肽之间的体外特性和生物分布相似。与I - c(RGDyK)和Br - c(RGDyK)相比,[I]SIB - 和[Br]SBrB - 偶联的RGD肽显示出更高的分配系数、更低的肿瘤摄取和更高的肠道摄取。与不具有连接子的[I]SIB - c(RGDfK)和[Br]SBrB - c(RGDfK)相比,具有乙二醇连接子的[I]SIB - EG - c(RGDfK)和[Br]SBrB - EG - c(RGDfK)降低了亲脂性和在肠道中的摄取。然而,[I]SIB - EG - c(RGDfK)和[Br]SBrB - EG - c(RGDfK)在生物分布方面的改善并不充分。总之,直接放射性卤化的c(RGDyK)肽在肿瘤成像和治疗方面可能比间接放射性卤化的肽更有用。